Formoterol/Budesonide

DRUG3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Eurofarma Laboratorios S.A.

Conditions

ASTHMAAsthmaObstructive Airway Disease

Phase 2

Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT

CompletedNCT00624754

Assistance Publique - Hôpitaux de ParisObstructive Airway Disease

Start: 2008-03-31End: 2012-07-31Updated: 2013-05-06

Phase 3

A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with Asthma

CompletedNCT01001364

Eurofarma Laboratorios S.A.ASTHMA

Start: 2010-02-28End: 2011-04-30Updated: 2025-03-19

A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma

CompletedNCT01167010

Eurofarma Laboratorios S.A.Asthma

Start: 2011-04-30End: 2012-02-29Updated: 2025-05-01

Related Papers

Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation

American Journal of Respiratory and Critical Care Medicine2015-04-02116 citations